First CRISPR drug could be approved soon – DW – 11/02/2023
A CRISPR drug to treat sickle cell disease may be approved by the US drug regulator next month.
Stay updated with breaking news from Gil Wolfe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A CRISPR drug to treat sickle cell disease may be approved by the US drug regulator next month.
Vertex Pharmaceuticals has hailed its treatment as "transformative" for patients with sickle cell disease. The FDA will decide on approval soon.
(CNN) — At age 45, Dr. Lakiea Bailey said, for the longest time, that she was the oldest person with sickle cell anemia that she knew. The executive<a class="excerpt-read-more" href="https://whdh.com/news/fda-considers-first-crispr-gene-editing-treatment-that-may-cure-sickle-cell/">Read More</a>
Long-term clinical trial and real-world data illustrate VYVGART® drives consistent, repeatable and clinically meaningful responses, including minimal symptom expression in generalized myasthenia...
Long-term clinical trial and real-world data illustrate VYVGART® drives consistent, repeatable and clinically meaningful responses, including mini...